These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29672173)

  • 1. The potential role of statins in preeclampsia and dyslipidemia during gestation: a narrative review.
    Maierean SM; Mikhailidis DP; Toth PP; Grzesiak M; Mazidi M; Maciejewski M; Banach M
    Expert Opin Investig Drugs; 2018 May; 27(5):427-435. PubMed ID: 29672173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can statins prevent pregnancy complications?
    Girardi G
    J Reprod Immunol; 2014 Mar; 101-102():161-167. PubMed ID: 24012117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pravastatin for Preventing and Treating Preeclampsia: A Systematic Review.
    Esteve-Valverde E; Ferrer-Oliveras R; Gil-Aliberas N; Baraldès-Farré A; Llurba E; Alijotas-Reig J
    Obstet Gynecol Surv; 2018 Jan; 73(1):40-55. PubMed ID: 29368790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the role of statins in prevention of preeclampsia: deeper insights into maternal cardiometabolic changes.
    Rao SJ; Martin SS; Lawson SM; Hailu T; Davis DM; Nasir K; Cainzos-Achirica M; Blumenthal RS; Sharma G
    J Clin Lipidol; 2022; 16(4):403-416. PubMed ID: 35668023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of statins on preeclampsia: A systematic review.
    Vahedian-Azimi A; Karimi L; Reiner Ž; Makvandi S; Sahebkar A
    Pregnancy Hypertens; 2021 Mar; 23():123-130. PubMed ID: 33333432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratogenic risk of statins in pregnancy.
    Godfrey LM; Erramouspe J; Cleveland KW
    Ann Pharmacother; 2012 Oct; 46(10):1419-24. PubMed ID: 23032657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins in pregnancy.
    Morton S; Thangaratinam S
    Curr Opin Obstet Gynecol; 2013 Dec; 25(6):433-40. PubMed ID: 24126785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.
    Ahmed MH; Al-Atta A; Hamad MA
    Expert Opin Pharmacother; 2012 Sep; 13(13):1901-9. PubMed ID: 22770622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and pregnancy: between supposed risks and theoretical benefits.
    Lecarpentier E; Morel O; Fournier T; Elefant E; Chavatte-Palmer P; Tsatsaris V
    Drugs; 2012 Apr; 72(6):773-88. PubMed ID: 22480340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia.
    Ermini L; Post M; Caniggia I
    Curr Mol Pharmacol; 2017; 10(2):152-160. PubMed ID: 26758951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of statins in the prevention of preeclampsia.
    Smith DD; Costantine MM
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1171-S1181. PubMed ID: 32818477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol, statins, and dementia: what the cardiologist should know.
    Wanamaker BL; Swiger KJ; Blumenthal RS; Martin SS
    Clin Cardiol; 2015 Apr; 38(4):243-50. PubMed ID: 25869997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between dyslipidemia and severity in preeclampsia].
    Duarte-Mote J; Perez-Torres C; Espinosa-López R; Eng-Castro VL; Calvo-Colindres J; Sánchez-Rojas G; Romero-Figueroa Mdel S
    Rev Med Inst Mex Seguro Soc; 2014; 52(5):516-20. PubMed ID: 25301126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
    Sahebkar A; Watts GF
    Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrate therapy in the management of dyslipidemias, alone and in combination with statins: role of delayed-release fenofibric acid.
    Schima SM; Maciejewski SR; Hilleman DE; Williams MA; Mohiuddin SM
    Expert Opin Pharmacother; 2010 Apr; 11(5):731-8. PubMed ID: 20210682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.
    Goldberg AC; Bittner V; Pepine CJ; Kelly MT; Thakker K; Setze CM; Lele A; Sleep DJ
    Am J Cardiol; 2011 Mar; 107(6):898-905. PubMed ID: 21247520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of statins on the expansion rate and rupture risk of abdominal aortic aneurysms.
    VAN KUIJK JP; FLU WJ; WITTEVEEN OP; VOUTE M; BAX JJ; POLDERMANS D
    J Cardiovasc Surg (Torino); 2009 Oct; 50(5):599-609. PubMed ID: 19741575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of PCSK9 monoclonal antibodies in statin-nonresponsive patients with hypercholesterolemia and dyslipidemia: A systematic review and meta-analysis.
    Peng W; Qiang F; Peng W; Qian Z; Ke Z; Yi L; Jian Z; Chongrong Q
    Int J Cardiol; 2016 Nov; 222():119-129. PubMed ID: 27494723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use and safety concerns: an overview of the past, present, and the future.
    Mulchandani R; Lyngdoh T; Kakkar AK
    Expert Opin Drug Saf; 2020 Aug; 19(8):1011-1024. PubMed ID: 32668998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are therapeutic LDL goals justified? Controversies between the European and American guidelines].
    Bertomeu-Martínez V
    Medwave; 2016 Dec; 16(Suppl4):e6825. PubMed ID: 28055995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.